{"name":"Zosano Pharma Corporation","slug":"zosano-pharma-corporation","ticker":"","exchange":"","domain":"","description":"","hq":"","founded":0,"employees":"","ceo":"","sector":"","stockPrice":0,"stockChange":0,"stockChangePercent":0,"marketCap":"","metrics":{"revenue":0,"revenueGrowth":0,"grossMargin":0,"rdSpend":0,"netIncome":0,"cash":0,"dividendYield":0,"peRatio":0,"fiscalYear":"FY2026"},"revenueBreakdown":[],"timeline":[{"date":"2026-07-28","label":"Q2 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2026-10-28","label":"Q3 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-01-28","label":"Q4 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-04-28","label":"Q1 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-07-28","label":"Q2 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-10-28","label":"Q3 2027 Earnings","type":"earnings","sentiment":"neutral"}],"diseaseAreas":[{"name":"Other","slug":"other","revenue":0,"percentOfTotal":0,"drugCount":2,"colorKey":"oncology","drugs":[{"name":"A: M207 3.8mg, 30 min, upper arm","genericName":"A: M207 3.8mg, 30 min, upper arm","slug":"a-m207-3-8mg-30-min-upper-arm","indication":"Other","status":"phase_1"},{"name":"C213 Microneedle System","genericName":"C213 Microneedle System","slug":"c213-microneedle-system","indication":"Other","status":"phase_2"}]},{"name":"Neuroscience","slug":"neuroscience","revenue":0,"percentOfTotal":0,"drugCount":1,"colorKey":"immunology","drugs":[{"name":"M207 Microneedle System","genericName":"M207 Microneedle System","slug":"m207-microneedle-system","indication":"Migraine (zolmitriptan delivery via microneedle patch)","status":"phase_3"}]}],"pipeline":[{"name":"A: M207 3.8mg, 30 min, upper arm","genericName":"A: M207 3.8mg, 30 min, upper arm","slug":"a-m207-3-8mg-30-min-upper-arm","phase":"phase_1","mechanism":"Small molecule","indications":[],"catalyst":""},{"name":"C213 Microneedle System","genericName":"C213 Microneedle System","slug":"c213-microneedle-system","phase":"phase_2","mechanism":"Small molecule","indications":[],"catalyst":""},{"name":"M207 Microneedle System","genericName":"M207 Microneedle System","slug":"m207-microneedle-system","phase":"phase_3","mechanism":"M207 is a microneedle patch system designed to deliver drugs transdermally by piercing the skin barrier with microscopic needles.","indications":["Migraine (zolmitriptan delivery via microneedle patch)"],"catalyst":""}],"recentEvents":[],"realNews":[{"url":"https://news.google.com/rss/articles/CBMiygJBVV95cUxNaXM4NDF5dUNyMEtBT2xObXg2bmFqM3A3UVZmRjZCUWZsWVFFVzhkSWNLdGJfaUgxVUVGT2c5aDd4XzMyWmFnOTBTaHlFYmpLcDExLUp2cmszaVFsSEREaGNad19TZFNlZDJuZjRObUZzemFBTmtWTk12ekY1elFtV1hTTUpJempaRjMzcFRzYzE5SmFBRVBxd3R6SjVpdV94TmlqeFExOU5fdWV2WGRLT0NPYUtrd2w3ajdkYVJGRzhidXc2TkVFY0pjSUdWcmZmWmRPVkl5bXdzTXFZaWR1SmV3akJWN1c4Y0prcjBVMkRiWDdYMWNYMUZQLW9uMlJLRlN6MWZnVVI4LUNncUp6UGVJSUZGLUlqS1RveVVQTkFad2ZXOGZMVDVxOWE4emhIalBJSDNoZkg4M0xoMDM4NTFvalY5eHZRcnc?oc=5","date":"2024-10-17","type":"pipeline","source":"globenewswire.com","summary":"Emergex Announces Company Name Change to “Gylden Pharma - globenewswire.com","headline":"Emergex Announces Company Name Change to “Gylden Pharma","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMikgFBVV95cUxQbTBtcHltT3NvSnV0UEdkWnA2RTJGbV9HWnZ4T0dFTl9DVFBFNzFmRUJIS2lFYjdSZEZDbTlKSmxSakJ0WDRvN3A4MjBuRnNKLWZuT3BURjIxT3Q0YUM5M0RfV241eks5MXdTdXd4VHpBaWpQUVJ0V0huMTZiODJiejlwMklWeGJYS091T0NaZ1BaUQ?oc=5","date":"2024-03-26","type":"pipeline","source":"intelligentinvestor.com.au","summary":"Zosano Pharma Corp (NASDAQ: ZSAN) - Share Price - intelligentinvestor.com.au","headline":"Zosano Pharma Corp (NASDAQ: ZSAN) - Share Price","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiZEFVX3lxTE9jdVlXd2lEX3FHdzJidTBYOVlBMU04Sm15V0ptbjh2OEpoTWZ0Wk4xcVFIQTY4NHVxTUMzc1ZxQ0o2U3RxWkViZWJ2MTZadFhBTVktdzFPeVZ3S2Y0Um9Nang4NmM?oc=5","date":"2022-11-17","type":"pipeline","source":"GuruFocus","summary":"Gerald J Kazma Net Worth (2026) - GuruFocus","headline":"Gerald J Kazma Net Worth (2026)","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiogFBVV95cUxOZUs5bjdiSFlfLTlFX0pxc0Z5dGlfVzBlem83eTR5Y2puLTB4RkhnczRycnNTT0tIX2ZZRXVSc3pyQjVKdl8wVzZ2N0xRdF8zLS11Um5JZFhORkk1ZmxnNE13SlQtQl9tSFhwa2UxTU9SWWNBbFIwQ3MxNDB0ckNqVURSTnpSWXllV0hSU3F6Z0NJRzd5YmFZejFHUjhNUU1YX1E?oc=5","date":"2022-10-18","type":"pipeline","source":"Fierce Pharma","summary":"Bankrupt Zosano sells intradermal delivery tech to Emergex Vaccines - Fierce Pharma","headline":"Bankrupt Zosano sells intradermal delivery tech to Emergex Vaccines","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiiAFBVV95cUxOR2VacjBER3Ruc3dDRC01OWx0YjM3MkpYTW1QMkhPLVBIb1k1MGtNUlhPR2VZZ240RmpaQ0hMZkp3UGJwa2t1VEdJSm1IaVBlZFRDTWJnUTlsQTdJTm13T1pLbUVNeWV3UEhham9VTVk4TmNLRjkyZjJQVjZxUGYxbEo4TzNtbjVq?oc=5","date":"2022-10-12","type":"deal","source":"finance.yahoo.com","summary":"Bankrupt Zosano Sells Its Drug Delivery Tech That Once Partnered With Pharma Giants - finance.yahoo.com","headline":"Bankrupt Zosano Sells Its Drug Delivery Tech That Once Partnered With Pharma Giants","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMilgFBVV95cUxQbkNjVURKaWNtMUVtYktpSjAxbzdQa2hWNEw5bEN6S3NuZkp3OEdZXzFhMTBSSzJxdWtVaDhXNnpGdEtmT1JCQWVfMlNfby04U0o4aElEWi03RnFkRzNrblFkanJRNDZCYV83cUpHd3VrazgwMnVkdXBqSWNsZG9Vc3hiQVl2b1pwQkQzSkRiMF9ESVZ5TVE?oc=5","date":"2022-10-12","type":"pipeline","source":"Labiotech.eu","summary":"Emergex looks to microneedle patches with Zosano Pharma acquisition - Labiotech.eu","headline":"Emergex looks to microneedle patches with Zosano Pharma acquisition","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMirAFBVV95cUxOV19hRGdtVFlRUFhpUEJKcDFXUG1nNDBYM2QxTnNxemZ2d2E3MkZ5MU5nVENmRUYwdHhXM2wzdkplRnhmMlpwZ3IwVUFnOV9aTGh3dzZlb3didUJDa25Ba0lNS1M2SHA1WXZoVFltWnRuMTdBY1NBTHdoRElMdENxWk53ajU2U2VSU3Blb2s1UkliUy14a1FiOFZRZ2pLbjBTNmdmNmhKU1h4eEVD?oc=5","date":"2022-10-05","type":"pipeline","source":"The Business Journals","summary":"Berkeley startup raises $28M, nabs ex-Zosano chief as CEO as it aims for the eye - The Business Journals","headline":"Berkeley startup raises $28M, nabs ex-Zosano chief as CEO as it aims for the eye","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMicEFVX3lxTE5ieWI2T1FOaUxKVTVzOXU5dlh2UW52N0d4RFRiRW9EY25XQThPR3REZVNiRkxjRGZudjBoWV93czVILVJHTWl0WElWNVBOalFjZFd0NVFkZjdzeExBT1RsSmdPRTVtZTU4S2RaV0lGWTg?oc=5","date":"2022-09-27","type":"pipeline","source":"GuruFocus","summary":"Gregory David Kitchener Net Worth (2026) - GuruFocus","headline":"Gregory David Kitchener Net Worth (2026)","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMipgFBVV95cUxNYUJzdTJYdWpyOFU1OHJqN2ljTlh3LW5ndVFPM0thc2hnSDlWeklWZEsyYUNhRTZoMFFKb0lhNk1EWncyMFN3ZXIzUF9XR3dyR2xNV1B5ZUM4RWtneDNxWlVaYkZKbUJjUFRSRUV1V3JwOVpRMEd5NXg4R1lUTjJNdmlENTlOSjg0YjQ0LWpUcjNnMVY1eHFad3oxNjNOb25LMXBWaTBB?oc=5","date":"2022-06-07","type":"regulatory","source":"Fierce Pharma","summary":"Zosano goes bankrupt after FDA rejects migraine drug delivery patch - Fierce Pharma","headline":"Zosano goes bankrupt after FDA rejects migraine drug delivery patch","sentiment":"negative"},{"url":"https://news.google.com/rss/articles/CBMiqgFBVV95cUxNUWRTeUxXcWNZS1otQVhuY2s3dm9qZ3JPcF9BbzJ2ZG84WmFIclZucFNoU0lHZ2tfUTQ5VjZMZjBTNEZZYWlZWElBVDNNMlpUeWJ0Y09FSWVCN3gtOXZZZlZUdlY0Y2pTTERzOHREdUwtRFIxRFJqbS1Ua3ZjSUhKM3BqdzB4Wm83ZU52R0p0bTVDZzh1NEl5RWRlYnZBRjQ2VjN0WVg1OXk0Zw?oc=5","date":"2022-06-02","type":"pipeline","source":"The Business Journals","summary":"East Bay migraine patch developer files for bankruptcy - The Business Journals","headline":"East Bay migraine patch developer files for bankruptcy","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiwwFBVV95cUxQNWZGRUNZS3dFWnBzX1d6VXBabF9wdEZWNWIyQTNpYnl1aUdhekI1Tk0xdUNsY21GaGZMVEFweVRaRDA1bEdUMzhfOXRlZFRQTFVub25DTGVjLVhnNVJEM2VIZzR1MmxndmNCZHROMzRsOTRlaVlXcFNBM01RQk1sRE16Q3pPem1MQmVzaHlSdk4xZUI0WWE0SjBDMV9JYmUwQmpiLURDSlpMRUpldjhxUTNEMmZkdE1WUmlVZ005Qk5ES0U?oc=5","date":"2022-03-17","type":"regulatory","source":"Fierce Biotech","summary":"Zosano's headaches continue: Biotech lays off 31% after FDA rejects migraine drug resubmission - Fierce Biotech","headline":"Zosano's headaches continue: Biotech lays off 31% after FDA rejects migraine drug resubmission","sentiment":"negative"},{"url":"https://news.google.com/rss/articles/CBMiwAFBVV95cUxNdHBGdGwwRFpkSkQtSEliNUEwUGVFbnBxNUNBdmNVaDcxWkhzMWhkXzlOdzFPLU9ZMjE2MUxqUUc5bUl3bW14UVczNmpqWVIwNGlEU2lMeTRtQ0p6TUxjQ2JnVWJFQlBGMmcxR3lQWW9oX1dzNzZ0dENKU1dCVkI3dUM4M2J3aUVzdUo0Nld2amFHdTF1MFJicEZXYi1CRkFGanVCcGJha2tuUFJib0VEYmRhMHA2Nks1S0s2MHkxWF8?oc=5","date":"2020-10-23","type":"regulatory","source":"Fierce Pharma","summary":"Zosano presses on after FDA rejects Qtrypta migraine patch - Fierce Pharma","headline":"Zosano presses on after FDA rejects Qtrypta migraine patch","sentiment":"negative"}],"patents":[],"drugCount":3,"phaseCounts":{"phase_1":1,"phase_2":1,"phase_3":1},"enrichmentLevel":0,"visitCount":1,"keyCompetitors":[],"therapeuticFocus":[],"financials":null,"yahoo":null}